Showing results (311-320 of 434) with videos related to

Sort By:
Pageof 44
Antimicrobial Agents and Chemotherapy|April 4, 1998
Zalcitabine population pharmacokinetics: application of radioimmunoassayJ M Adams, M J Shelton, R G Hewitt, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Indinavir, efavirenz, and abacavir pharmacokinetics in human immunodeficiency virus-infected subjectsRobert DiCenzo, Alan Forrest, Kathleen E Squires, et al.
The American Journal on Addictions|February 2, 2006
Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdineElinore F McCance-Katz, Petrie M Rainey, Patrick Smith, et al.
Therapeutic Drug Monitoring|February 17, 2007
Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and applicationKim Keil, Jill Hochreitter, Robin DiFrancesco, et al.
Therapeutic Drug Monitoring|September 21, 2013
Clinical pharmacology quality assurance program: models for longitudinal analysis of antiretroviral proficiency testing for international laboratoriesRobin DiFrancesco, Susan L Rosenkranz, Charlene R Taylor, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1993
Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complexR G Hewitt, G D Morse, W D Lawrence, et al.
Bioanalysis|June 10, 2016
Development and validation of a UPLC-MS/MS method for the simultaneous determination of paritaprevir and ritonavir in rat liverAndrew J Ocque, Colleen E Hagler, Robin Difrancesco, et al.
Expert Review of Clinical Pharmacology|August 9, 2017
Evaluation of CYP2D6 phenotype in the Yoruba Nigerian populationWaheed Adeola Adedeji, Sharon Iyobor Igbinoba, Titilayo O Fakeye, et al.
Pharmacogenetics and Genomics|February 22, 2014
Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202Daniel H Johnson, Charles Venuto, Marylyn D Ritchie, et al.
Antiviral Therapy|September 8, 2012
ITX 5061 quantitation in human plasma with reverse phase liquid chromatography and mass spectrometry detectionJill Hochreiter, Jill Lapham, Flossie Wong-Staal, et al.
Pageof 44